emphasized that a higher ratio of PD-1+ Tregs to PD-1+ CD8+ T cells in the tumor microenvironment signals adverse responses to PD-1 blockade, because PD-1+ Tregs exhibit enhanced immunosuppression upon PD-1 inhibition (18). Here, CD8A is linked to neoplasm.